FR3034418B1 - Utilisation de combinaisons particulieres de carbohydrates pour stabiliser des proteines, et compositions proteiques contenant de telles combinaisons - Google Patents

Utilisation de combinaisons particulieres de carbohydrates pour stabiliser des proteines, et compositions proteiques contenant de telles combinaisons Download PDF

Info

Publication number
FR3034418B1
FR3034418B1 FR1552899A FR1552899A FR3034418B1 FR 3034418 B1 FR3034418 B1 FR 3034418B1 FR 1552899 A FR1552899 A FR 1552899A FR 1552899 A FR1552899 A FR 1552899A FR 3034418 B1 FR3034418 B1 FR 3034418B1
Authority
FR
France
Prior art keywords
combinations
carbohydrates
compositions containing
protein compositions
stabilizing proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1552899A
Other languages
English (en)
French (fr)
Other versions
FR3034418A1 (fr
Inventor
Merveille NONO
Nicolas Descamps
Denis Simon
Olfa Haeusler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roquette Freres SA
Original Assignee
Roquette Freres SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1552899A priority Critical patent/FR3034418B1/fr
Application filed by Roquette Freres SA filed Critical Roquette Freres SA
Priority to US15/563,871 priority patent/US10822372B2/en
Priority to JP2017551685A priority patent/JP6857613B2/ja
Priority to CN201680018706.8A priority patent/CN107531747A/zh
Priority to DK16718427.4T priority patent/DK3277702T3/da
Priority to EP16718427.4A priority patent/EP3277702B1/fr
Priority to PCT/FR2016/050709 priority patent/WO2016156734A1/fr
Publication of FR3034418A1 publication Critical patent/FR3034418A1/fr
Application granted granted Critical
Publication of FR3034418B1 publication Critical patent/FR3034418B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01002—Beta-amylase (3.2.1.2)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
FR1552899A 2015-04-03 2015-04-03 Utilisation de combinaisons particulieres de carbohydrates pour stabiliser des proteines, et compositions proteiques contenant de telles combinaisons Active FR3034418B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR1552899A FR3034418B1 (fr) 2015-04-03 2015-04-03 Utilisation de combinaisons particulieres de carbohydrates pour stabiliser des proteines, et compositions proteiques contenant de telles combinaisons
JP2017551685A JP6857613B2 (ja) 2015-04-03 2016-03-30 タンパク質の安定化
CN201680018706.8A CN107531747A (zh) 2015-04-03 2016-03-30 蛋白质的稳定
DK16718427.4T DK3277702T3 (da) 2015-04-03 2016-03-30 Stabilisering af proteiner
US15/563,871 US10822372B2 (en) 2015-04-03 2016-03-30 Use of particular combinations of carbohydrates for stabilizing proteins, and protein compositions containing such combinations
EP16718427.4A EP3277702B1 (fr) 2015-04-03 2016-03-30 Stabilisation de proteines
PCT/FR2016/050709 WO2016156734A1 (fr) 2015-04-03 2016-03-30 Stabilisation de proteines

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1552899A FR3034418B1 (fr) 2015-04-03 2015-04-03 Utilisation de combinaisons particulieres de carbohydrates pour stabiliser des proteines, et compositions proteiques contenant de telles combinaisons
FR1552899 2015-04-03

Publications (2)

Publication Number Publication Date
FR3034418A1 FR3034418A1 (fr) 2016-10-07
FR3034418B1 true FR3034418B1 (fr) 2018-09-28

Family

ID=53483991

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1552899A Active FR3034418B1 (fr) 2015-04-03 2015-04-03 Utilisation de combinaisons particulieres de carbohydrates pour stabiliser des proteines, et compositions proteiques contenant de telles combinaisons

Country Status (7)

Country Link
US (1) US10822372B2 (enExample)
EP (1) EP3277702B1 (enExample)
JP (1) JP6857613B2 (enExample)
CN (1) CN107531747A (enExample)
DK (1) DK3277702T3 (enExample)
FR (1) FR3034418B1 (enExample)
WO (1) WO2016156734A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7039308B2 (ja) * 2017-02-08 2022-03-22 三洋化成工業株式会社 細胞培養用担体
CN108424035A (zh) * 2018-04-19 2018-08-21 中原工学院 一种聚合物水泥发泡剂及其发泡混凝土的制备方法
US20220170002A1 (en) * 2019-03-11 2022-06-02 Nagase Chemtex Corporation Amylase composition

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE229810T1 (de) 1985-07-09 1987-11-05 Quadrant Bioresources Ltd., Soulbury, Leighton Buzzard, Bedfordshire Beschuetzung von proteinen und aehnlichem.
GB9010742D0 (en) * 1990-05-14 1990-07-04 Quadrant Bioresources Ltd Stabilization of biological macromolecular substances
CA2177429A1 (en) * 1995-06-29 1996-12-30 Charles Allen Rodgers Reduced fat cheese-flavored snack filling
US5876992A (en) * 1996-07-03 1999-03-02 Molecular Biology Resources, Inc. Method and formulation for stabilization of enzymes
WO2000062759A1 (en) * 1999-04-16 2000-10-26 Novo Nordisk A/S Dry, mouldable drug formulation
FI20021312L (fi) * 2002-07-03 2004-01-04 Danisco Sweeteners Oy Polyolikoostumusten kiteyttäminen, kiteinen polyolikoostumustuote ja sen käyttö
CN1681392B (zh) * 2002-09-11 2010-06-09 普瑞图斯股份有限公司 具有木聚糖分解活性的家族8酶在焙烤中的应用
EP1574567A1 (en) * 2004-03-11 2005-09-14 Puratos Naamloze Vennootschap Novel xylanases and their use
SI1954308T1 (sl) * 2005-09-16 2011-12-30 Merial Ltd Stabilizatorji za liofilizirana cepiva
EP2627318B1 (en) * 2010-10-12 2017-08-16 Merz Pharma GmbH & Co. KGaA Formulation suitable for stabilizing proteins, which is free of mammalian excipients
RU2470520C1 (ru) * 2011-07-18 2012-12-27 Валентина Андреевна Васькина Способ производства нуги "мандариновой"
ES2574956T3 (es) * 2011-09-26 2016-06-23 Preanalytix Gmbh Estabilización y aislamiento de ácidos nucleicos extracelulares
CN102533689A (zh) * 2011-12-30 2012-07-04 华东师范大学 一种谷氨酰胺转胺酶真空干燥的制备方法
CN103159839B (zh) * 2013-03-28 2014-07-30 云南天保桦生物资源开发有限公司 热稳定保护的α-淀粉酶抑制剂及其用途
WO2015021600A1 (en) * 2013-08-13 2015-02-19 Danisco Us Inc. Beta-amylase and methods of use
CN104099313B (zh) * 2014-07-18 2016-04-06 天津天绿健科技有限公司 一种啤酒液体复配酶

Also Published As

Publication number Publication date
DK3277702T3 (da) 2023-12-04
JP2018516239A (ja) 2018-06-21
US10822372B2 (en) 2020-11-03
CN107531747A (zh) 2018-01-02
US20180118779A1 (en) 2018-05-03
EP3277702A1 (fr) 2018-02-07
WO2016156734A1 (fr) 2016-10-06
JP6857613B2 (ja) 2021-04-14
EP3277702B1 (fr) 2023-09-06
FR3034418A1 (fr) 2016-10-07

Similar Documents

Publication Publication Date Title
IL285702A (en) Heterocyclic amides useful as protein modulators
IL282704A (en) De novo binding domain containing polypeptides and uses thereof
EP3423451A4 (en) INHIBITORS OF WDR5 PROTEIN PROTEIN BINDING
MX2020003596A (es) Composiciones de acido nucleico-polipeptido y usos de las mismos.
EA201890926A1 (ru) ТРИАЗОЛОВЫЕ ИНГИБИТОРЫ АЦЕТИЛ-КоА-КАРБОКСИЛАЗЫ И ВАРИАНТЫ ИХ ПРИМЕНЕНИЯ
EP3390429A4 (en) MODIFIED CAPSID PROTEINS FOR IMPROVED DELIVERY OF PARVOVIRUS VECTORS
EP3302706A4 (en) COMPOSITIONS AND METHODS FOR REMOVING MISINTEGRATED PROTEINS
DK3743420T3 (da) Heterocyclylamino-substituerede triazoler som modulatorer af rho-associeret proteinkinase
EA201792500A1 (ru) Aav-опосредованная экспрессия антител против гриппа и способы их использования
EP3554272A4 (en) DRIED FLAKES WITH ACTIVE INGREDIENTS
EP3563853C0 (en) COMPOSITION OF MANNURONIC DIACID
EP3679031A4 (en) INHIBITORS OF WDR5 PROTEIN PROTEIN BINDING
DK3143138T3 (da) Betinget aktive biologiske proteiner
HUE050964T2 (hu) Heteroaril amidok mint protein aggregáció inhibitorai
MA56416A (fr) Détermination de la pureté de protéines multimériques
EP3395187A4 (en) GELARY FOOD COMPOSITION
DK3240436T3 (da) Sammensætning indeholdende kitin og fordøjelige proteiner
IL269100A (en) Stabilized protein-bound cannabinoid compositions
DK3313864T3 (da) Rekombinante virusvektorer indeholdende prrsv minor protein og fremgangsmåder til fremstilling og anvendelse deraf
PL3350334T3 (pl) Ekspresja rekombinowanych białek w poczwarkach trichoplusia ni
KR20180084853A (ko) 지혈 조성물
EP3436049A4 (en) ANGIOPOIETIN-SIMILAR PROTEIN 8 (ANGPTL8)
DK3259358T3 (da) Forøget proteinekspression
HUE047445T2 (hu) Pirazol-származékok, amelyek 5-lipoxigenáz aktiváló fehérje (FLAP) gátlókként használhatók
EP3357062C0 (en) DYNAMIC MODIFICATION OF AUDIO CONTENT

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20161007

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11